Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

720 ARTÍCULOS , VIENDO DEL 46 AL 60

The role of ATP-binding cassette transporter G1 (ABCG1) in Alzheimer's disease: A review of the mechanisms

Yazdi MK, Alavi MS, Roohbakhsh A.

Basic Clin Pharmacol Toxicol. 2024 Apr;134(4):423-438. doi: 10.1111/bcpt.13981. Epub 2024 Jan 26.

Disentangling tau: One protein, many therapeutic approaches

Lane-Donovan C, Boxer AL.

Neurotherapeutics. 2024 Mar;21(2):e00321. doi: 10.1016/j.neurot.2024.e00321. Epub 2024 Jan 25.

Converged avenues: depression and Alzheimer's disease- shared pathophysiology and novel therapeutics

Bajaj S, Mahesh R.

Mol Biol Rep. 2024 Jan 28;51(1):225. doi: 10.1007/s11033-023-09170-1.

Lessons Learned from Approval of Aducanumab for Alzheimer's Disease

Heidebrink JL, Paulson HL.

Annu Rev Med. 2024 Jan 29;75:99-111. doi: 10.1146/annurev-med-051022-043645.

Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management

Singh B, Day CM, Abdella S, Garg S.

J Control Release. 2024 Mar;367:402-424. doi: 10.1016/j.jconrel.2024.01.047. Epub 2024 Feb 1.

A comprehensive review of multi-target directed ligands in the treatment of Alzheimer's disease

Pathak C, Kabra UD.

Bioorg Chem. 2024 Mar;144:107152. doi: 10.1016/j.bioorg.2024.107152. Epub 2024 Jan 27.

Brain cholesterol and Alzheimer's disease: challenges and opportunities in probe and drug development

Ahmed H, Wang Y, Griffiths WJ, Levey AI, Pikuleva I, Liang SH, Haider A.

Brain. 2024 May 3;147(5):1622-1635. doi: 10.1093/brain/awae028.

A Comprehensive Review on Potential Molecular Drug Targets for the Management of Alzheimer's Disease

Sharma C, Mazumder A.

Cent Nerv Syst Agents Med Chem. 2024;24(1):45-56. doi: 10.2174/0118715249263300231116062740.

Marine-derived Compounds: A Powerful Platform for the Treatment of Alzheimer's Disease

Arora R, Babbar R, Dabra A, Chopra B, Deswal G, Grewal AS.

Cent Nerv Syst Agents Med Chem. 2024;24(2):166-181. doi: 10.2174/0118715249269050231129103002.

Muscarinic control of cardiovascular function in humans: a review of current clinical evidence

Palma JA.

Clin Auton Res. 2024 Feb;34(1):31-44. doi: 10.1007/s10286-024-01016-5. Epub 2024 Feb 2.

A systematic review and meta-analysis of tau phosphorylation in mouse models of familial Alzheimer's disease

Kourti M, Metaxas A.

Neurobiol Dis. 2024 Mar;192:106427. doi: 10.1016/j.nbd.2024.106427. Epub 2024 Feb 1.

Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways

Sinha JK, Trisal A, Ghosh S, Gupta S, Singh KK, Han SS, Mahapatra M, Abomughaid MM, Abomughayedh AM, Almutary AG, Iqbal D, Bhaskar R, Mishra PC, Jha SK, Jha NK, Singh AK.

Ageing Res Rev. 2024 Apr;96:102211. doi: 10.1016/j.arr.2024.102211. Epub 2024 Feb 1.

Could protein phosphatase 2A and glycogen synthase kinase-3 beta be targeted by natural compounds to ameliorate Alzheimer's pathologies?

Manoharan SD, Abdul Hamid H, Md Hashim NF, Cheema MS, Chiroma SM, Mustapha M, Mehat MZ.

Brain Res. 2024 Apr 15;1829:148793. doi: 10.1016/j.brainres.2024.148793. Epub 2024 Feb 1.

Therapeutic potential of the medicinal mushroom Ganoderma lucidum against Alzheimer's disease

Chen XJ, Deng Z, Zhang LL, Pan Y, Fu J, Zou L, Bai Z, Xiao X, Sheng F.

Biomed Pharmacother. 2024 Mar;172:116222. doi: 10.1016/j.biopha.2024.116222. Epub 2024 Feb 3.

The effects of probiotic supplements on oxidative stress and inflammation in subjects with mild and moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled study

Akhgarjand C, Vahabi Z, Shab-Bidar S, Anoushirvani A, Djafarian K.

Inflammopharmacology. 2024 Apr;32(2):1413-1420. doi: 10.1007/s10787-023-01427-2. Epub 2024 Feb 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias